Andrea Bedini is Associate Professor of Pharmacology at the Department of Pharmacy and Biotechnology, University of Bologna (Italy); on March 2023 he obtained the National Habilitation to Full Professor. 

Prof. Bedini earned both his MSc degree in Medical Biotechnology with honors, and his PhD degree in Cellular and Molecular Biotechnology with outstanding grades at the University of Bologna. He was Visiting Scientist at the Department of Pharmacology and Toxicology, University of Magdeburg (Germany) from August 2006 to February 2007, under the supervision of Prof. Volker Hoellt and Dr. Juergen Kraus, and Visiting Scholar in Prof. Charles Chavkin’s research group at the Department of Pharmacology, University of Washington (Seattle, USA) from February 2013 to February 2014. 

Prof. Bedini’s research has been first focused on the transcriptional modulation of mu-opioid receptor expression in neuronal and immune cells, then on the characterization of innovative mu and kappa opioid ligands with improved pharmacological profiles and on understanding the molecular determinants of such ameliorated profiles. Prof. Bedini’s current research focuses on applying molecular and cellular pathway analyses to the development of Quantitative Systems Pharmacology platforms aimed to identify more effective and safer analgesic treatments; within this frame, he recently received a prestigious EU-funded Horizon 2020 grant as team leader of the University of Bologna unit. 

In July 2023, Prof. Bedini was awarded the 2023 Young Investigator Award by the International Narcotics Research Conference.